Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome (Q44009269)

28 November 2017

title

Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome (English)

1 reference

28 November 2017

Nobutaka Hattori

1 reference

28 November 2017

Yoshikuni Mizuno

1 reference

28 November 2017

Barry Halliwell

1 reference

28 November 2017

Shin-Ichiro Kubo

1 reference

28 November 2017

Dong-Hoon Hyun

1 reference

28 November 2017

MoonHee Lee

series ordinal

1 reference

28 November 2017

Peter Jenner

series ordinal

1 reference

28 November 2017

language of work or name

English

0 references

publication date

28 May 2002

1 reference

Journal of Biological Chemistry

28 November 2017

published in

1 reference

28 November 2017

volume

277

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

28572-28577

1 reference

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Parkin and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Reactive oxygen-mediated protein oxidation in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Proteasomal function is impaired in substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Impairment of the ubiquitin-proteasome system by protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Deadly encounter: ubiquitin meets apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Failure of the ubiquitin-proteasome system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

The copper transport protein Atox1 promotes neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Impaired clearance of oxidised proteins in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Parkin is associated with cellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Mitochondrial free radical generation, oxidative stress, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Modifications of proteins by polyunsaturated fatty acid peroxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Loss of 3-Nitrotyrosine on Exposure to Hypochlorous Acid: Implications for the Use of 3-Nitrotyrosine as a Bio-markerin Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Association of IgM type anti‐GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Molecular genetic analysis of a novelParkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in theParkin gene in affected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Analysis of the parkin deletion in sporadic and familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Association studies of Parkinson's disease and parkin polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

A fluorometric method for determination of oxidized and reduced glutathione in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Oxidative damage and motor neurone disease difficulties in the measurement of protein carbonyls in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Oxidative damage to proteins: spectrophotometric method for carbonyl assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

High-performance liquid chromatography-based thiobarbituric acid tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Impaired proteasome function in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200666200

21 January 2018

Identifiers

DOI

10.1074/JBC.M200666200

1 reference

28 November 2017

1 reference